GRGDSPK

CAS No. 111119-28-9

GRGDSPK ( EMD 56574 )

Catalog No. M21025 CAS No. 111119-28-9

GRGDSPK is an inhibitory peptide for RGD-mediated adhesion between integrin and extracellular matrix molecules.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 315 Get Quote
10MG 567 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    GRGDSPK
  • Note
    Research use only not for human use.
  • Brief Description
    GRGDSPK is an inhibitory peptide for RGD-mediated adhesion between integrin and extracellular matrix molecules.
  • Description
    GRGDSPK is an inhibitory peptide for RGD-mediated adhesion between integrin and extracellular matrix molecules.
  • Synonyms
    EMD 56574
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    111119-28-9
  • Formula Weight
    715.76
  • Molecular Formula
    C28H49N11O11
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N=C(N)NCCCC(NC(=O)CN)C(=O)NCC(=O)NC(CC(=O)O)C(=O)NC(CO)C(=O)N1CCCC1C(=O)NC(CCCCN)C(=O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Sessions B R Aston K I Davis A P et al. Effects of amino acid substitutions in and around the arginine-glycine-aspartic acid (RGD) sequence on fertilization and parthenogenetic development in mature bovine oocytes[J]. Molecular Reproduction and Development 2006 73(5):651-657.
molnova catalog
related products
  • Bicine

    Bicine is an organic compound used as a biological buffer.

  • Albiglutide TFA (782...

    Albiglutide TFA, a glucagon-like peptide (GLP)-1 mimetic, is a long acting GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus (T2DM).

  • ANP (1-28), human, p...

    Atrial natriuretic peptide (ANP), a stimulator of particulate guanylate cyclase, has been found to protect against reoxygenation-induced hypercontracture in isolated cardiomyocytes by increasing cyclic guanosine monophosphate synthesis; ANP also contributes to stimulation of lipolysis during repeated bouts of exercise and in the control of lipolysis during exercise.